摘要
背景:许多研究报告了心血管疾病的流行和治疗中的性别和性别差异。然而,高血压治疗中的性别差异尚未完全确定。 目的:评估抗高血压治疗后患者的性别特异性差异,使用现有研究的荟萃分析。 方法:从1990年1月至2015年1月,对Medline和SCOPUS数据库进行系统的文献检索,分别对高血压治疗后男性和女性受试者的临床结果进行评估。使用随机效应模型进行定量数据合成,其中称重平均差(WMD)和95%置信区间(CI)作为汇总统计。 结果:分析包括10项16例治疗组的研究。发现结果在男性当中比女性更为频繁(优势比[OR]:1.25,95%置信区间[CI]:1.17,1.33,p <0.001; I2:40.17%),这一结果是稳健的独立。随机效应meta回归显示结果与治疗持续时间和基线水平无关。 结论:本次荟萃分析显示,与同期治疗高血压患者相比,男性临床疗效更为频繁。许多原因,包括依从性的差异,年龄和男性内在的高风险,有助于证明这些发现的正当性。
关键词: 性别,性别,血压,结果,抗高血压治疗,高血压。
Current Medicinal Chemistry
Title:Comparison of Clinical Outcomes Between Genders Following Antihypertensive Therapy: A Meta-Analysis
Volume: 24 Issue: 24
关键词: 性别,性别,血压,结果,抗高血压治疗,高血压。
摘要: Background: Numerous studies have reported sex and gender differences in the prevalence and treatment of cardiovascular diseases. However, sex differences in the therapy of hypertension have not been completely examined.
Objective: To estimate the gender-specific dissimilarity in outcomes among patients following antihypertensive treatment, using a meta-analysis of available studies. Methods: A systematic literature search in Medline and SCOPUS databases was performed from January 1990 to January 2015 to find studies assessing clinical outcomes in male and female subjects after hypertension treatment, separately. Quantitative data synthesis was performed using a random-effects model, with weighed mean difference (WMD) and 95% confidence interval (CI) as summary statistics. Results: the analysis included 10 studies with 16 treatment arms. Outcomes were found to be significantly more frequent in men then in women (odds ratio [OR]: 1.25, 95% confidence interval [CI]: 1.17, 1.33, p < 0.001; I2:40.17%), and this result was robust and independent. Random-effects meta-regression showed no association of outcomes with treatment duration and baseline levels. Conclusion: The present meta-analysis demonstrates that clinical outcomes are more frequent in men compared with women after the same treatment of hypertension. Numerous reasons, including disparities in compliance, age, and intrinsic higher risk in male, contribute to justify these findings.Export Options
About this article
Cite this article as:
Comparison of Clinical Outcomes Between Genders Following Antihypertensive Therapy: A Meta-Analysis, Current Medicinal Chemistry 2017; 24 (24) . https://dx.doi.org/10.2174/0929867323666161213160440
DOI https://dx.doi.org/10.2174/0929867323666161213160440 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Saphenous Vein as a Bypass Conduit: The Potential Role of Vascular Nerves in Graft Performance
Current Vascular Pharmacology Sildenafil and Cardioprotection
Current Pharmaceutical Design Androgen Metabolic Pathway Involved in Current and Emerging Treatment for Men with Castration Resistant Prostate Cancer: Intraprostatic Androgens as Therapeutic Targets and Endocrinological Biomarkers
Current Drug Targets Biomarkers in Atrial Fibrillation and Heart Failure
Current Medicinal Chemistry Adipokines and Myokines: A Pivotal Role in Metabolic and Cardiovascular Disorders
Current Medicinal Chemistry Current Status of Carotid Stenting
Current Vascular Pharmacology Review of Evidence and Perspectives of Flavonoids on Metabolic Syndrome and Neurodegenerative Disease
Protein & Peptide Letters Nebulizable Cycloserine Loaded PLGA Nanoparticles: Formulation Design, in vitro Evaluation and Stability Studies
Current Nanomedicine Fitness or Fatness: The Debate Continues for AMP-Activated Protein Kinase in Heart Function
Current Cardiology Reviews The Renal Outer Medullary Potassium Channel (ROMK): An Intriguing Pharmacological Target for an Innovative Class of Diuretic Drugs
Current Medicinal Chemistry Perioperative Considerations in Rheumatoid Arthritis Patients
Current Rheumatology Reviews Gender Differences in Characteristics and Outcome in Primary Intraventricular Hemorrhage
Current Neurovascular Research Pathophysiology, Diagnosis and Clinical Management of Hepatorenal Syndrome: From Classic to New Drugs
Current Vascular Pharmacology Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins be Key Mediators of this Association?
Current Pharmaceutical Biotechnology Drug-Membrane Interactions: Significance for Medicinal Chemistry
Current Medicinal Chemistry Are Patient Self-Report Questionnaires as "Scientific" as Biomarkers in "Treat-totarget" and Prognosis in Rheumatoid Arthritis?
Current Pharmaceutical Design Calcium Channel Blockers - Benefits Upon Vascular Biology in Hypertensive Patients
Cardiovascular & Hematological Agents in Medicinal Chemistry Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
Current Pharmaceutical Design Management of Obesity in Pregnancy
Current Women`s Health Reviews Understanding eNOS for Pharmacological Modulation of Endothelial Function: A Translational View
Current Pharmaceutical Design